Stock listing
NASDAQ:JNP Juniper Pharmaceuticals Inc Stock
Follow Juniper Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:JNP
$11.50 USD
Close on Aug 13, 2018 · No longer trades
- Lowest – highest close
- $3.85 – $140.96 USDSince Dec 31, 1997 · lowest Apr 13, 2017 · highest Mar 10, 2000
Delisted NASDAQ:JNP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:JNP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alicia Secor Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past) | President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past |
| James Geraghty Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Jul 17, 2019); Voyager Therapeutics, Inc. (Director · Since at least Jun 15, 2016); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Palvella Therapeutics, Inc. (Director · May 22, 2017 – Dec 12, 2024 · Past); Aceragen Inc. (Director · May 13, 2016 – Jun 23, 2022 · Past) | Director · Aug 2, 2016 – Aug 14, 2018 · Past |
| C Ann Merrifield Other companies: Lyra Therapeutics, Inc. (Director · Apr 30, 2020 – May 14, 2025 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 8, 2014 – Nov 17, 2022 · Past); Flexion Therapeutics Inc (Director · Jun 11, 2014 – Nov 19, 2021 · Past) | Director · Jul 16, 2015 – Aug 14, 2018 · Past |
| Jennifer Good Other companies: Rhythm Pharmaceuticals, Inc. (Director · Since at least Jun 19, 2019); Trevi Therapeutics, Inc. (President and Chief Executive Officer · Since at least May 7, 2019); Penwest Pharmaceuticals Co (President & CEO · Apr 28, 2010 – Nov 4, 2010 · Past) | Director · Sep 7, 2017 – Aug 14, 2018 · Past |
| Stephen G. Kasnet Other companies: Granite Point Mortgage Trust Inc. (Chair of the Board and Independent Director · Since at least Jun 22, 2017); Two Harbors Investment Corp (Director · Since at least Feb 14, 2012); Silver Bay Realty Trust Corp (Director · Dec 14, 2012 – May 9, 2017 · Past) | Director · Jun 7, 2012 – May 8, 2014 · Past |
| George O. Elston Other companies: EyePoint, Inc. (Executive Vice President, Chief Financial Officer · Since at least Nov 14, 2019); Celldex Therapeutics, Inc. (Director · Jun 20, 2012 – Jun 8, 2016 · Past) | Chief Financial Officer · Oct 1, 2014 – Aug 31, 2016 · Past |
| Jeffrey E Young Other companies: Harvard Apparatus Regenerative Technology Inc (Director · Nov 6, 2018 – Jun 25, 2020 · Past); Tempest Therapeutics, Inc. (Chief Financial Officer · Sep 8, 2014 – Dec 3, 2015 · Past) | Chief Financial Officer · Jan 1, 2017 – Aug 14, 2018 · Past |
| Frank Condella Jr Other companies: Ivax Corp (Pres. IVAX Pharm. Europe · Jan 26, 2006 – Jan 26, 2006 · Past) | Director · Mar 10, 2009 – Aug 2, 2016 · Past |
| Jones Jonathan Brian Lloyd Other companies: Palisade Bio, Inc. (Chief Financial Officer · May 18, 2015 – Mar 24, 2017 · Past) | Vice President & CFO · Jan 15, 2013 – May 5, 2014 · Past |
| Frank M Armstrong | Director · Sep 12, 2013 – Jun 30, 2017 · Past |
All 12 people
| Person | Seat |
|---|---|
| Lawrence A Gyenes | Senior Vice President · Feb 29, 2012 – Feb 29, 2012 · Past |
| Valerie Lynne Andrews | Director · Jul 2, 2010 – May 8, 2014 · Past |
Log in to ask 6ix AI your own questions about Juniper Pharmaceuticals Inc.